LSTA

Lisata Therapeutics, Inc. Common Stock
Data: 2026-02-02
$4.56
Price
-1.30%
Change
$4.8918
52W High
$1.81
52W Low

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Quick Stats
Feb 02, 2026

54.3

AI Score

HOLD

0.27

Volume Ratio

Feb 26, 2026

Next Earnings

15

+ve Days (30d)

14

-ve Days (30d)

LSTA Stock Summary

Last updated Feb 02, 2026

LSTA is currently trading at $4.56, positioned above its 200-day moving average of $2.47, indicating a long-term uptrend. The stock has a 52-week range of $1.81 to $4.8918.

Technical Analysis: The 50-day moving average stands at $2.44, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 86.278, suggesting the stock is in overbought territory (bullish but caution advised).

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.372, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LSTA at 54.3/100 with a HOLD recommendation.

LSTA (Lisata Therapeutics, Inc. Common Stock) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 86.278
CMF (20) -0.372
ROC (10) 111.111
ADX (14) 50.359
Indicator Value
MACD (12,26,9) 0.69
AROONOSC (14) 71.429
WILLAMS %R (14) -11.554
MFI (14) 86.406
LSTA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

LSTA Price vs Max Options Open Interest
LSTA Max Change In Options Open Interest

LSTA Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

LSTA Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

LSTA Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

LSTA Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Lisata Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

LSTA Moving Averages Analysis

Lisata Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026

Lisata Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026

LSTA (Lisata Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 4.14
20 3.1
30 2.73
50 2.44
100 2.41
200 2.47

LSTA Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 40.8 million
Earnings/Share ($) -2.13
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.325
EPS Estimate Next Year ($) -1.025
WallStreet Target Price ($) 11.3333
Most Recent Quarter